Neurological Biomarkers Market

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.

Neurological Biomarkers Market contains market size and forecasts of Neurological Biomarkers in global, including the following market information:

• Global Neurological Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Neurological Biomarkers Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Neurological Biomarkers companies in 2021 (%)

The global Neurological Biomarkers market was valued at 7137.8 million in 2021 and is projected to reach US$ 15280 million by 2028, at a CAGR of 11.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Proteomics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neurological Biomarkers include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, Roche, Illumina, Bio-Rad Laboratories, QIAGEN and Myriad RBM, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurological Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neurological Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Neurological Biomarkers Market Segment Percentages, by Type, 2021 (%)

• Proteomics
• Genomics
• Imaging
• Bioinformatics
• Others

Global Neurological Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Neurological Biomarkers Market Segment Percentages, by Application, 2021 (%)

• Diagnostics
• Drug Discovery
• Personalized Medicine
• Others

Global Neurological Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Neurological Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Neurological Biomarkers revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Neurological Biomarkers revenues share in global market, 2021 (%)
• Key companies Neurological Biomarkers sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Neurological Biomarkers sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Merck
• Quest Diagnostics
• Abbott
• Roche
• Illumina
• Bio-Rad Laboratories
• QIAGEN
• Myriad RBM
• Cisbio Bioassays
• Athena Diagnostics
• BGI
• Wuxi APP
• Aepodia
• Proteome Sciences
• Genewiz